Answers are grounded in this paper and cite their sources.
Aspirin and warfarin may be a viable alternative antithrombotic strategy for patients with both clopidogrel low response and ticagrelor hypersensitivity.
Ticagrelor is widely used to treat acute coronary syndrome. Hypersensitivity reaction of ticagrelor is rarely recognized. A low response to clopidogrel, which occurs in up to 23% of patients, is an independent risk factor for stent thrombosis. Management of patients with a low response to clopidogrel and ticagrelor hypersensitivity who are undergoing antithrombotic therapy remains to be a challenge. Herein, we report a patient with low response to clopidogrel and ticagrelor hypersensitivity, who was successfully managed using aspirin and warfarin.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: